Injectables - Somatropin for Injection
Growth Hormone Deficiency is a medical condition in which the body does not produce enough somatropin, growth hormone. The incidence of idiopathic GHD in infants is about 1 in every 3800 live births, and rates in older children are rising as more children survive childhood cancers which are treated with radiotherapy, although exact rates are hard to obtain. The incidence of genuine adult-onset GHD, normally due to pituitary tumours, is estimated at 10 per million.
Growth hormone deficiency has different effects at different ages. In later infancy and childhood, growth failure is more likely. Deficiency in adults is rare, but may feature diminished lean body mass, poor bone density, and a number of physical and psychological symptoms.
|
|
Somatropin for Injection |
|
|
|
| |
|
| Additional information about Somatropin for Injection,
Norditropin and
other products may be found in our
Clinical Resources
section, If You need additional information regarding any of these
products please contact BDI
Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |